MarginsXMarginsX
Home › Markets › CTRVP

Hepion Pharmaceuticals, Inc. (CTRVP)

CTRVP is quoted over the counter, not listed on an exchange. Hepion Pharmaceuticals, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Last trade · August 14, 2025
$0.0013
No trades since Aug 14, 2025; later closes repeat the last quote
1-year return
0.0%
Market cap
Another share class (preferred); the SEC share count is the common shares, so no cap for this line
P/E and P/S
Needs a market cap · Needs a market cap
On trailing twelve months to June 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerCTRVP, quoted over the counter
SEC CIK0001583771
OTC Markets tierOTCID (price source, 2026-11-13)
SEC industry codePharmaceutical Preparations
Business addressRed Bank, NJ
Incorporated inDE

Warning signs

Cash runway
12.3 months
$1.6M cash at June 30, 2026
Share count, 1 year
+676.4%
2025-08-14 to 2026-08-10 · +117425.4% over 3 years
Going-concern doubt
Yes
10-Q filed August 13, 2026
Insider net buying, 12 months
$175K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"Due to our recurring and expected continuing losses from operations, we have concluded there is substantial doubt in our ability to continue as a going concern within one year of the issuance of these condensed consolidated financial statements without additional capital becoming available to us."
10-Q 2026-08-13
Cash and burn$1.6M cash; operating cash flow -$399K a quarter.Report 2026-06-30
Shares outstanding90,219,317 (2026-08-10); 11,620,317 a year earlier; 3,838,289 three years earlier. 3y figure adjusted for splits (1-for-50 overall).Cover page 2026-08-10
Reverse splits, 3 years1; latest 1-for-50 on 2025-03-18Source 2025-03-18
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
Delisting25-NSE filed25-NSE 2025-07-22
AuditorGrassi & Co., CPAs, P.C., Jericho, New York, United States; changed auditors 1 time in 24 months8-K 4.01 2026-09-28
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $175K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
Not filed-$1.2M-$1.4M$1.6M$0Needs four quarters10-Q 2026-08-13
Q1 2026
2026-03-31
Not filed-$811K$579K$2.6M$0Needs four quarters10-Q 2026-08-13
Q4 2025
2025-12-31
Not filed-$657K-$333K$1.8M$54KNeeds four quarters10-K 2026-03-12
Q3 2025
2025-09-30
Not filed-$473K-$446K$2.3M$214KNeeds four quarters10-Q 2025-11-12
Q2 2025
2025-06-30
Not filed-$1.0M-$1.4M$2.9M$372KNeeds four quarters10-Q 2026-08-13
Q1 2025
2025-03-31
Not filed-$6.1M-$1.1M$4.6M$526KNeeds four quarters10-Q 2026-08-13
Q4 2024
2024-12-31
Not filed-$1.5M-$1.2M$406K$2.9MNeeds four quarters10-K 2026-03-12
Q3 2024
2024-09-30
Not filed-$4.9M-$2.5M$1.5M$2.1MNeeds four quarters10-Q 2025-11-12

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B42025-01-23
Latest annual report10-K2026-03-12
Latest quarterly / interim10-Q2026-11-16
Latest current report8-K2026-10-09
Latest proxyDEFA14A2026-04-28

Source: SEC EDGAR submissions feed, 724 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier